90 related articles for article (PubMed ID: 3906228)
1. Interleukin 2 production by peripheral blood lymphocytes in allograft recipients during acute rejection episodes.
Vie H; Bonneville M; Cariou R; Moreau JF; Soulillou JP
Kidney Int; 1985 Sep; 28(3):553-7. PubMed ID: 3906228
[TBL] [Abstract][Full Text] [Related]
2. Increased interleukin II production during kidney allograft rejection.
Vie H; Bonneville M; Cariou R; Moreau JF; Soulillou JP
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():1006-9. PubMed ID: 3887368
[TBL] [Abstract][Full Text] [Related]
3. [Clinical value of interleukin 1- and interleukin 2-determinations in patients after kidney transplantation].
Buchwald S; Friemel H; Plantikow A; Hudemann B; Bast R; Templin R
Allerg Immunol (Leipz); 1990; 36(3):137-45. PubMed ID: 2256457
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic assessment of the in vivo cyclosporine effect on interleukin-2 production by lymphocytes in kidney transplant recipients.
Yoshimura N; Kahan BD
Transplantation; 1985 Dec; 40(6):661-6. PubMed ID: 3934806
[TBL] [Abstract][Full Text] [Related]
5. Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease.
Soulillou JP; Douillard JY; Vie H; Harousseau JL; Guenel J; le Mevel-le Pourhiet A; le Mevel B
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):935-9. PubMed ID: 3876220
[TBL] [Abstract][Full Text] [Related]
6. Serum & urinary interleukin-2 levels as predictors in acute renal allograft rejection.
Gupta RK; Jain M; Sharma RK
Indian J Med Res; 2004 Jan; 119(1):24-7. PubMed ID: 14997990
[TBL] [Abstract][Full Text] [Related]
7. [The level of IL-2 and IL-6 in stimulated peripheral lymphocyte supernatants of kidney transplant recipients can predict acute renal allograft rejection].
Jin Z; Xu C; Duan W; Yang J; Tian P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Aug; 33(8):1024-1029. PubMed ID: 28871940
[TBL] [Abstract][Full Text] [Related]
8. [The mechanism of donor specific unresponsiveness in renal transplant recipients].
Okimoto T; Yahata H; Fukuda Y; Dohi K
Nihon Rinsho Meneki Gakkai Kaishi; 1998 Jun; 21(3):118-28. PubMed ID: 9754014
[TBL] [Abstract][Full Text] [Related]
9. Immunological monitoring and early prediction of rejection in renal allograft recipients.
Attallah AM; Abdelghaffar H; Alghraoui F; Fawzy A; Alijani MR; Mahmoud LA; Ghoneim MA; Helfrich GB
Int Arch Allergy Appl Immunol; 1987; 84(1):10-7. PubMed ID: 3305373
[TBL] [Abstract][Full Text] [Related]
10. Correlation of in vitro CD4+ T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients.
Muluk SC; Clerici M; Via CS; Weir MR; Kimmel PL; Shearer GM
Transplantation; 1991 Aug; 52(2):284-91. PubMed ID: 1678559
[TBL] [Abstract][Full Text] [Related]
11. Noncytolytic human lymphocytes injure dermal microvessels in the huPBL-SCID skin graft model.
Rayner D; Nelson R; Murray AG
Hum Immunol; 2001 Jun; 62(6):598-606. PubMed ID: 11390034
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine.
Iacono A; Dauber J; Keenan R; Spichty K; Cai J; Grgurich W; Burckart G; Smaldone G; Pham S; Ohori NP; Yousem S; Williams P; Griffith B; Zeevi A
Transplantation; 1997 Jul; 64(2):263-9. PubMed ID: 9256185
[TBL] [Abstract][Full Text] [Related]
13. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
Elliott LH; Brooks WH; Roszman TL
J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
[TBL] [Abstract][Full Text] [Related]
14. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.
Nashan B; Moore R; Amlot P; Schmidt AG; Abeywickrama K; Soulillou JP
Lancet; 1997 Oct; 350(9086):1193-8. PubMed ID: 9652559
[TBL] [Abstract][Full Text] [Related]
15. Heightened peripheral blood lymphocyte CD69 expression is neither sensitive nor specific as a noninvasive diagnostic test for renal allograft rejection.
Karpinski M; Rush D; Jeffery J; Pochinco D; Milley D; Nickerson P
J Am Soc Nephrol; 2003 Jan; 14(1):226-33. PubMed ID: 12506155
[TBL] [Abstract][Full Text] [Related]
16. Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients.
Yoshimura N; Oka T; Kahan BD
Transplantation; 1991 Jan; 51(1):172-6. PubMed ID: 1987687
[TBL] [Abstract][Full Text] [Related]
17. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
[TBL] [Abstract][Full Text] [Related]
18. Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients.
Simpson MA; Madras PN; Cornaby AJ; Etienne T; Dempsey RA; Clowes GH; Monaco AP
Transplantation; 1989 Feb; 47(2):218-23. PubMed ID: 2645701
[TBL] [Abstract][Full Text] [Related]
19. Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome.
Daniel V; Naujokat C; Sadeghi M; Weimer R; Renner F; Yildiz S; Opelz G
Transpl Int; 2008 Jul; 21(7):646-60. PubMed ID: 18298587
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of whole blood cyclosporine measurements in renal transplantation using triple therapy.
Nankivell BJ; Hibbins M; Chapman JR
Transplantation; 1994 Nov; 58(9):989-96. PubMed ID: 7974738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
